Protein kinase CK2 accumulation in “oncophilic” cells: causes and effects

CX-4945, an Orally Bioavailable Selective Inhibitor of Protein Kinase CK2, Inhibits Prosurvival and Angiogenic Signaling and Exhibits Antitumor Efficacy

Adam Siddiqui-Jain, Denis Drygin, Nicole Streiner et al. · Cancer Research · 2010 · 501 citations

PTEN posttranslational inactivation and hyperactivation of the PI3K/Akt pathway sustain primary T cell leukemia viability

Ana Silva, José Andrés Yunes, Bruno A. Cardoso et al. · Journal of Clinical Investigation · 2008 · 441 citations · Full text

Pten Activity, Signal Transduction, Cell Regulation +14

Protein kinase CK2 inhibitor 4,5,6,7-tetrabromobenzotriazole (TBB) induces apoptosis and caspase-dependent degradation of haematopoietic lineage cell-specific protein 1 (HS1) in Jurkat cells

Maria Ruzzene, Daniele Penzo, Lorenzo A. Pinna · Biochemical Journal · 2002 · 219 citations · Full text

Protein Kinase Ck2, Apoptosis, Immunology +16

Protein Kinase CK2α as an Unfavorable Prognostic Marker and Novel Therapeutic Target in Acute Myeloid Leukemia

Jin Seok Kim, Ju In Eom, June‐Won Cheong et al. · Clinical Cancer Research · 2007 · 191 citations · Full text

Multiple myeloma cell survival relies on high activity of protein kinase CK2

Francesco Piazza, Maria Ruzzene, Carmela Gurrieri et al. · Blood · 2006 · 134 citations